BioPharma Credit PLC (LON:BPCR)

London · Delayed Price · Currency is GBP · Price in USD

0.9800

0.00 (0.00%)

Aug 26, 2026, 4:35 PM GMT

BioPharma Credit Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	157.75	157.75	150.03	135.74	218.17	103.88
Revenue Growth	1.99%	5.14%	10.53%	-37.78%	110.02%	-5.58%
Gross Profit	157.75	157.75	150.03	135.74	218.17	103.88
Operating Income	129.85	129.85	122.18	108.46	182.34	84.98
Net Income	129.89	129.89	122.18	108.45	182.31	84.96
Earnings Per Share	0.11	0.11	0.10	0.08	0.13	0.06
EPS Growth	8.71%	14.03%	20.68%	-38.03%	116.14%	-4.68%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	12.59	12.59	5.62	135.05	120.53	94.71
Net Cash Growth	192.38%	123.97%	-95.84%	12.05%	27.26%	-51.00%
Net Cash Per Share	0.01	0.01	0.00	0.10	0.09	0.07
Cash & Investments	12.59	12.59	5.62	135.05	120.53	94.71

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	91.1	91.1	111.91	123.18	184.28	96.44
Free Cash Flow	91.1	91.1	111.91	123.18	184.28	96.44
Free Cash Flow Growth	-7.07%	-18.60%	-9.15%	-33.15%	91.09%	66.06%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	82.31%	82.31%	81.44%	79.90%	83.58%	81.80%
Pretax Margin	82.34%	82.34%	81.44%	79.90%	83.56%	81.79%
Profit Margin	82.34%	82.34%	81.44%	79.90%	83.56%	81.79%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.053	0.070	0.070	0.070	0.070	0.070
Dividend Per Share Growth	-2.31%	0%	0%	0%	0%	0%
Dividend Yield	7.33%	8.20%	9.49%	11.21%	11.15%	12.35%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	8.60	7.96	8.59	10.09	6.87	15.65
PS Ratio	6.88	6.56	7.00	8.06	5.74	12.80